Eli Lilly and Co (LLY)
786.23
-25.58
(-3.15%)
USD |
NYSE |
Nov 14, 16:00
784.89
-1.34
(-0.17%)
After-Hours: 20:00
Eli Lilly Net Income (TTM): 8.370B for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.370B |
| June 30, 2024 | 7.342B |
| March 31, 2024 | 6.138B |
| December 31, 2023 | 5.240B |
| September 30, 2023 | 4.988B |
| June 30, 2023 | 6.498B |
| March 31, 2023 | 5.687B |
| December 31, 2022 | 6.245B |
| September 30, 2022 | 6.033B |
| June 30, 2022 | 5.692B |
| March 31, 2022 | 6.129B |
| December 31, 2021 | 5.582B |
| September 30, 2021 | 5.972B |
| June 30, 2021 | 6.071B |
| March 31, 2021 | 6.092B |
| December 31, 2020 | 6.194B |
| September 30, 2020 | 5.573B |
| June 30, 2020 | 5.618B |
| March 31, 2020 | 5.533B |
| December 31, 2019 | 8.318B |
| September 30, 2019 | 7.948B |
| June 30, 2019 | 7.843B |
| March 31, 2019 | 6.256B |
| December 31, 2018 | 3.232B |
| September 30, 2018 | 450.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -143.80M |
| March 31, 2018 | 1.124B |
| December 31, 2017 | -204.10M |
| September 30, 2017 | 2.225B |
| June 30, 2017 | 2.447B |
| March 31, 2017 | 2.187B |
| December 31, 2016 | 2.738B |
| September 30, 2016 | 2.444B |
| June 30, 2016 | 2.466B |
| March 31, 2016 | 2.319B |
| December 31, 2015 | 2.408B |
| September 30, 2015 | 2.358B |
| June 30, 2015 | 2.059B |
| March 31, 2015 | 2.192B |
| December 31, 2014 | 2.390B |
| September 30, 2014 | 2.690B |
| June 30, 2014 | 3.392B |
| March 31, 2014 | 3.865B |
| December 31, 2013 | 4.685B |
| September 30, 2013 | 4.785B |
| June 30, 2013 | 4.908B |
| March 31, 2013 | 4.626B |
| December 31, 2012 | 4.089B |
| September 30, 2012 | 4.120B |
| June 30, 2012 | 4.029B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
4.988B
Minimum
Sep 2023
8.370B
Maximum
Sep 2024
6.166B
Average
6.052B
Median
Net Income (TTM) Benchmarks
| Amgen Inc | 4.23B |
| Biogen Inc | 1.615B |
| Johnson & Johnson | 14.68B |
| Viking Therapeutics Inc | -99.15M |
| Moderna Inc | -2.224B |